Tolerability and Efficacy of Intravenous Infusion of Autologous MSC_Apceth for the Treatment of Critical Limb Ischemia

This study is currently recruiting participants. (see Contacts and Locations)
Verified March 2014 by Apceth GmbH & Co. KG
Sponsor:
Information provided by (Responsible Party):
Apceth GmbH & Co. KG
ClinicalTrials.gov Identifier:
NCT01351610
First received: May 10, 2011
Last updated: March 4, 2014
Last verified: March 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)